Clinical Trial Update: Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing SZC with enhanced nutrition advice versus standard of care in dialysis patients with hyperkalemia; study terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• SZC (sodium zirconium cyclosilate)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalaemia | Phase 4 | Status: TERMINATED | Results posted: 2023-01-19